Skip to content

WHO removes three Ranbaxy antiretrovirals from prequalification list due to failings in research procedures

Study looks at risky sex amongst 3700 HIV-positive Americans

Final APRICOT and ACTG 5071 HIV/HCV coinfection results published

US approval for once daily abacavir/3TC and tenofovir/FTC pills

UK government criticised for failure to act on TB

Genetics influence response to HAART and incidence of pancreatitis, studies show

Atazanavir: final phase III results published

Report of rare atazanavir-related liver side-effect published

Treatment Action Group releases policy recommendations on HIV/hepatitis C coinfection